tirzepatide 2.5 mg/0.5 ml pnij Mounjaro pre-filled single-dose pen Images GLP-2 Tirzepatide (40mg vials) -
Description
Additionally, it is not suitable for individuals with pancreatitis, diabetic retinopathy, kidney issues, gallbladder disease, severe gastroparesis, or type 1 diabetes

Intractable nausea, vomiting, or abdominal pain may indicate the need for dose reduction, temporary treatment interruption, or evaluation for other causes

Rosenstock J, Wysham C, Fras JP, Kaneko S, Lee CJ, Fernndez Land L, et al

Both sites ultimately deliver the full dose into your bloodstream
